Nephrol Dial Transplant (2000) 15: 72-73
© 2000 European Renal Association-European Dialysis and Transplant Association
Pathophysiology of Tubulointerstitial Disease
Morphometry of interstitial fibrosis
1 Departments of Pathology and 2 Nephrology, Leiden University Medical Centre, Leiden, The Netherlands
Abstract
Several clinical studies have confirmed that histomorphometric changes in the tubulointerstitial compartment contain the best correlating parameters to predict the development of progressive renal insufficiency. The process of interstitial fibrosis is accompanied by an influx of inflammatory cells, up-regulation of fibrogenic cytokines such as transforming growth factor-ß and basic fibroblast growth factor, transient down-modulation of their antagonists, generation and proliferation of myofibroblasts, and finally, by accumulation of interstitial collagens and proteoglycans. A careful morphometric analysis of interstitial fibrosis requires sensitive parameters through which the severity can be quantified and by which the progression into renal insufficiency can be predicted. We have addressed these issues by morphometric analysis of both human biopsies and by refining existing experimental models in the rat. Morphometric analysis was performed using a Zeiss microscope equipped with a full colour 3CCD camera and KS-400 image analysis software from Zeiss-Kontron. For studies with human material, biopsies were examined from patients with various renal diseases including patients with chronic allotransplant dysfunction. The development of interstitial fibrosis was correlated with clinical parameters. In experimental models, we analysed the interstitial composition and eventual glomerular alterations in rats with bovine serum albumin (BSA)-induced protein overload nephropathy and with human IgG-induced chronic serum sickness nephritics. Finally, we adapted and refined the model of ureter obstruction-induced interstitial fibrosis in the rat. For this purpose, custom-made titanium clips (S&T, Neuhaus, Switzerland) were implanted around the ureter in the abdomen of rats to obstruct the ureter without causing necrosis. The clips were removed at various time points after obstruction of the ureter (1–14 days). The subsequent remodelling of the interstitium was studied thereafter, in order to establish whether uraemia-induced interstitial fibrosis remains reversible at all times. In rat models, we have found that both protein overload-induced and serum sickness-induced interstitial fibrosis are accompanied by the development of focal and segmental glomerulosclerosis. Only in the ureter obstruction model did selective interstitial fibrosis develop, and remained reversible at all times studied. For the reliable assessment of interstitial fibrosis we have found that the best correlating parameters of interstitial fibrosis with renal function were: (i) the ratio of protein accumulation of TGF-ß-1 and its antagonist decorin; (ii) interstitial expression of smooth muscle 
-actin; and (iii) accumulation of interstitial collagens (as determined by immunoperoxidase and by Sirius red staining).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Pang, J. Kothapally, H. Mao, E. Tolbert, M. Ponnusamy, Y. E. Chin, and S. Zhuang Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy Am J Physiol Renal Physiol, October 1, 2009; 297(4): F996 - F1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Bakker, K. Koop, Y. W. Sijpkens, M. Eikmans, I. M. Bajema, E. de Heer, J. A. Bruijn, and L. C. Paul Early Interstitial Accumulation of Collagen Type I Discriminates Chronic Rejection from Chronic Cyclosporine Nephrotoxicity J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2142 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, C. Dai, and Y. Liu Hepatocyte Growth Factor Suppresses Renal Interstitial Myofibroblast Activation and Intercepts Smad Signal Transduction Am. J. Pathol., August 1, 2003; 163(2): 621 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rossert, B. Fouqueray, and J. J. Boffa Anemia Management and the Delay of Chronic Renal Failure Progression J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S173 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shimizu, S. Maruyama, Y. Yuzawa, T. Kato, Y. Miki, S. Suzuki, W. Sato, Y. Morita, H. Maruyama, K. Egashira, et al. Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Renal Injury Induced by Protein-Overload Proteinuria J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1496 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Eikmans, H. J. Baelde, E. C. Hagen, L. C. Paul, P. H. C. Eilers, E. de Heer, and J. A. Bruijn Renal mRNA Levels as Prognostic Tools in Kidney Diseases J. Am. Soc. Nephrol., April 1, 2003; 14(4): 899 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rossert, W. M. McClellan, S. D. Roger, and D. L. Verbeelen Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression? Nephrol. Dial. Transplant., March 1, 2002; 17(3): 359 - 362. [Full Text] [PDF]
|
|